Literature DB >> 73540

The revised structure of capreomycin.

S Nomoto, T Teshima, T Wakamiya, T Shiba.   

Abstract

The total structures of capreomycins IA and IB were determined mainly from the results of the comparative study on the NMR spectra of capreomycins and tuberactinomycins, resulting in a revision of the formerly proposed structure. The beta-lysine residue as a branched part was revealed to be linked with the beta-amino group of the alpha, beta-diaminopropionic acid residue in the cyclic pentapeptide moiety in a different manner than in tuberactinomycins.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 73540     DOI: 10.7164/antibiotics.30.955

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

1.  Enantiomeric free radicals and enzymatic control of stereochemistry in a radical mechanism: the case of lysine 2,3-aminomutases.

Authors:  E Behshad; F J Ruzicka; S O Mansoorabadi; D Chen; G H Reed; P A Frey
Journal:  Biochemistry       Date:  2006-10-24       Impact factor: 3.162

2.  Stereocontrolled Total Synthesis of Muraymycin D1 Having a Dual Mode of Action against Mycobacterium tuberculosis.

Authors:  Katsuhiko Mitachi; Bilal A Aleiwi; Christopher M Schneider; Shajila Siricilla; Michio Kurosu
Journal:  J Am Chem Soc       Date:  2016-09-26       Impact factor: 15.419

3.  Activity of di-beta-lysyl-capreomycin IIA and palmitoyl tuberactinamine N against drug-resistant mutants with altered ribosomes.

Authors:  T Yamada; T Teshima; T Shiba
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

4.  A biomimetic domino reaction for the concise synthesis of capreomycidine and epicapreomycidine.

Authors:  Martin Büschleb; Markus Granitzka; Dietmar Stalke; Christian Ducho
Journal:  Amino Acids       Date:  2012-05-23       Impact factor: 3.520

Review 5.  α,β-Dehydroamino acids in naturally occurring peptides.

Authors:  Dawid Siodłak
Journal:  Amino Acids       Date:  2014-10-17       Impact factor: 3.520

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.